MedPath

RISING PHARMA HOLDINGS, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

127

FDA:127

Drug Approvals

Levetiracetam

Approval Date
May 22, 2025
FDA

SODIUM CITRATE AND CITRIC ACID

Approval Date
May 15, 2025
FDA

Memantine Hydrochloride

Approval Date
Apr 19, 2025
FDA

Albuterol Sulfate

Approval Date
Apr 17, 2025
FDA

Albuterol Sulfate

Approval Date
Apr 17, 2025
FDA

Gabapentin

Approval Date
Apr 1, 2024
FDA

Gabapentin

Approval Date
Mar 29, 2024
FDA

Efavirenz

Approval Date
Mar 19, 2024
FDA

PREGABALIN

Approval Date
Mar 8, 2024
FDA

fingolimod

Approval Date
Mar 1, 2024
FDA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 13
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.